Gene:
DRD4
dopamine receptor D4

Overview

Alternate Names: D(2C) dopamine receptor; seven transmembrane helix receptor
Alternate Symbols: D4DR
PharmGKB Accession Id: PA27480

Details

Cytogenetic Location: chr11 : p15.5
GP mRNA Boundary: chr11 : 627305 - 630703
GP Gene Boundary: chr11 : 617305 - 633703
Strand: plus
Product Name: D(2C) dopamine receptor, dopamine receptor D4, see also Acc#: L12398, seven transmembrane helix receptor
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Curated Annotations (Curated Annotation)

  1. rs3758653 at chr11:626399 in DRD4, SCT
    This variant along with 3 other SNPs near DRD4 (4 SNP haplotype: rs3758653; rs916457; rs762502; rs11246226) is associated with tardive dyskinesia in male schizophrenia patients.
    Related Diseases:
    Schizophrenia, tardive dyskinesia
    Evidence:
    PMID:19238168
  2. rs916457 at chr11:627014 in DRD4, SCT
    This variant along with 3 other SNPs near DRD4 (4 SNP haplotype: rs3758653; rs916457; rs762502; rs11246226) is associated with tardive dyskinesia in male schizophrenia patients.
    Related Diseases:
    Schizophrenia, tardive dyskinesia
    Evidence:
    PMID:19238168
  3. rs762502 at chr11:630119 in DRD4
    This variant in exon 3 of DRD4 along with 3 other SNPs near DRD4 (4 SNP haplotype: rs3758653; rs916457; rs762502; rs11246226) is associated with tardive dyskinesia in male schizophrenia patients.
    Variant Name:
    DRD4:Cys290Cys; T870C
    Related Diseases:
    Schizophrenia, tardive dyskinesia
    Evidence:
    PMID:19238168
  4. rs11246226 at chr11:631191 in DRD4
    This variant along with 3 other SNPs near DRD4 (4 SNP haplotype: rs3758653; rs916457; rs762502; rs11246226) is associated with tardive dyskinesia in male schizophrenia patients.
    Related Diseases:
    Schizophrenia, tardive dyskinesia
    Evidence:
    PMID:19238168
Variant names are different names that have been used in the literature and other resources to refer to the same variant.

Non-Curated Information

A list of non-curated publications that mention this gene along with other genes is available.

PharmGKB Curated Pathways

Curated Information

The following drugs are in curated knowledge about this gene.

  Drug Class Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
antipsychotics
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
thioxanthene derivatives
  • CO
  •   
  •   
  •   
  • GN
Publications
  Drug Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
amisulpride
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
clozapine
  • CO
  • PD
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
fluspirilene
  • CO
  •   
  •   
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
haloperidol
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
methylphenidate
  • CO
  •   
  •   
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
nicotine
  • CO
  • PD
  •   
  •   
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
olanzapine
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
perazine
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
quetiapine
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
risperidone
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
ziprasidone
  • CO
  •   
  •   
  •   
  • GN
Publications

Non-Curated Information

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information

The following diseases are in curated knowledge about this gene.

  Disease Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
Attention Deficit Disorder with Hyperactivity
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Body Weight Changes
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Personality Disorders
  •   
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Psychotic Disorders
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Schizophrenia
  • CO
  • PD
  •   
  •   
  • GN
Publications, Variants
No phenotype data No genotype data Literature annotations available Not annotated
tardive dyskinesia
  • CO
  •   
  •   
  •   
  • GN
Publications, Variants
No phenotype data No genotype data Literature annotations available Not annotated
Tobacco Use Disorder
  • CO
  • PD
  •   
  •   
  • GN
Publications, Pathways

Non-Curated Information

A list of non-curated publications that mention this gene along with other diseases is available.

LinkOuts

Common Searches

Non-Curated Publications

A list of non-curated publications that mention this gene is available.

The PharmGKB is financially supported by the NIH/ NIGMS and is managed at Stanford University (U01GM61374).
©2001-2010 PharmGKB.